Scientists Switch On Nerve Regeneration Once Thought Lost Forever
Cambridge researchers found a gene network that shuts off nerve repair — and an existing hormone drug that reactivates it.
1.236 artigos
Cambridge researchers found a gene network that shuts off nerve repair — and an existing hormone drug that reactivates it.
Genetic testing for health risks has a 40% false-positive rate and often outperformed by lifestyle factors. Here's what the evidence shows.
Bepirovirsen, an antisense oligonucleotide, delivered functional cures in ~20% of chronic hepatitis B patients — a landmark leap over existing therapies.
Dermatologists explain how UV damage accumulates over time, why repair mechanisms matter, and what actually drives skin cancer risk.
Struggling to follow conversations at parties may reflect faster brain thinning in key cognitive regions, even before cognitive decline shows up on tests.
Durvalumab plus BCG cuts recurrence risk by nearly a third in high-risk bladder cancer patients, marking a major treatment milestone.
A landmark study finds Alzheimer's biomarkers in 6% of middle-aged adults, predicting steep cognitive decline within 5 years.
New research shows inhaled CBD reduces neuroinflammation in Alzheimer's mice, suggesting a multi-target therapeutic approach to the disease.
New research reveals how mutant lung cells reprogram surrounding tissue into a tumor-friendly niche — before cancer is even detectable.
Altos Labs' PRiMeFlow algorithm predicts cellular gene expression changes from interventions, outperforming rivals on key benchmarks.
Insilico Medicine and Human Longevity's HLFM merge AI muscle with decade-long multi-omic data to predict and prevent age-related disease.
A novel antibody targeting inflammation in diabetic eye disease enters Phase 1b trials, with early data expected by end of 2026.